The FDA has approved Durolane for treatinf pain from knee OA.
New drugs indicated for central nervous system and gastrointestinal disorders, infection, cancer treatment, and diabetes were reviewed.
Researchers examined smoking status, alcohol consumption, and body mass index as variables impacting patients' risk of osteoarthritis development or progression.
In patients with knee OA, intra-articular ozone may provide pain relief, functional improvement, and gains of QoL.
Pain is reduced after total hip arthroplasty by adding a sciatic nerve block to a continuous femoral nerve block.
Patients using a personalized risk calculator were guided to a more accurate perception of their knee OA risk.
Electrotherapy and acupuncture may benefit pain management after total knee arthroplasty.
Better results may come from sonography-guided hyaluronic acid injection rather than surface anatomy-guided injection in knee arthritis patients.
Bone density at the hip declined twice as quickly in HIV-infected eomen vs men.
Diclofenac used at the maximum dos of 150 mg/day was shown to be the most effective NSAID for the treatment of osteoarthritis.